{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Celcuity Inc."},"Symbol":{"label":"Symbol","value":"CELC"},"Address":{"label":"Address","value":"16305 36TH AVENUE NORTH,SUITE 100, MINNEAPOLIS, Minnesota, 55446, United States"},"Phone":{"label":"Phone","value":"+1 763 392-0767"},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR)."},"CompanyUrl":{"label":"Company Url","value":"https://www.celcuity.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brian F. Sullivan","title":"Chairman & Chief Executive Officer"},{"name":"Igor Gorbatchevsky","title":"Chief Medical Officer"},{"name":"John R. MacDonald","title":"Senior Vice President-R&D"},{"name":"Lance G. Laing","title":"Secretary, Director & Chief Science Officer"},{"name":"Nadene Zack","title":"VP-Clinical Operations"},{"name":"Pratima Nayak","title":"Vice President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}